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Abstract
Background—Maternal periodontal disease is a chronic oral infection with local and systemic 
inflammatory responses and may be associated with adverse pregnancy outcomes. This study 
determined whether maternal periodontal disease in early pregnancy is associated with elevated 
serum C-reactive protein (CRP) levels and whether maternal race influences the relationship 
between maternal periodontal disease and systemic inflammatory responses.
Methods—A secondary analysis of prospectively collected data from the Oral Conditions and 
Pregnancy study was conducted. Healthy women at <26 weeks of gestation underwent an oral 
health examination and had blood collected. Periodontal disease was categorized by clinical 
criteria, and maternal serum was analyzed for CRP levels using highly sensitive enzyme-linked 
immunosorbent assay kits. An elevated CRP level was defined as >75th percentile. Demographic 
and medical data were obtained from the women’s charts. Chi-square and multivariable logistic 
regression models were used to determine maternal factors associated with an elevated CRP. An 
adjusted odds ratio (OR) for elevated CRP levels was calculated and stratified by race and 
periodontal disease category.
Results—The median (interquartile) CRP level was 4.8 (0.6 to 15.7) μg/ml, and an elevated CRP 
level (>75th percentile) was 15.7 μg/ml. African American race and moderate/severe periodontal 
disease were significantly associated with elevated CRP levels. When stratified by race, moderate/
severe periodontal disease remained associated with an elevated CRP level among African 
American women (adjusted OR: 4.0; 95% confidence interval [CI]: 1.2 to 8.5) but not among 
white women (adjusted OR: 0.9; 95% CI: 0.2 to 3.6) after adjusting for age, smoking, parity, 
marital status, insurance status, and weight.
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Conclusion—Among African American women, moderate/severe periodontal disease is 
associated with elevated CRP levels early in pregnancy.
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Gingivitis and periodontitis are two periodontal conditions of significance during pregnancy. 
Gingivitis is an infectious and inflammatory condition of the superficial gingival tissues, 
with prevalence estimates during pregnancy ranging from 30% to 100%.1 Periodontitis is a 
more severe condition affecting 5% to 20% of pregnant women, and results in the 
destruction of tooth-supporting structures. 2,3 Among non-pregnant and pregnant 
individuals, periodontal disease is more common among African Americans; when present, 
it is likely to be more severe than in whites.4 The reasons for the racial disparity in the 
prevalence and severity of periodontal disease remain unclear and may be to due to racial 
differences in the oral microflora, inflammatory responses to oral pathogens, and cultural, 
environmental, and socioeconomic conditions.5 Studies indicate that different racial groups 
possess differing patterns of bacterial colonization6,7 as well as genetic polymorphisms that 
predispose to proinflammatory cytokine responses.8
Recent evidence suggests that maternal periodontal disease is associated with adverse 
pregnancy outcomes including early pregnancy loss, preterm birth, low birth weight, and 
preeclampsia.9,10 However, interventions to improve periodontal health during pregnancy 
and reduce these adverse pregnancy outcomes have produced disparate results.11–16 The 
underlying mechanism is unknown, but it has been hypothesized that systemic inflammatory 
responses may be involved.17 Individuals with periodontal disease also have a moderate 
systemic inflammatory response as evidenced by elevations in serum acute-phase reactants 
such as fibrinogen and C-reactive protein (CRP).17,18 CRP is believed to be a highly 
sensitive, albeit non-specific, marker of inflammatory status and may reflect infectious 
burden. CRP is higher among pregnant women compared to non-pregnant women19 and is 
higher among women with periodontal disease compared to periodontally healthy women.20 
A study21 suggested that African American women have higher CRP levels compared to 
white women. We hypothesize that exposure to oral pathogens leads to elevated 
inflammatory responses in early pregnancy and that maternal race influences this response. 
In this study, we investigated the relationships among maternal periodontal disease, maternal 
systemic inflammation, and maternal race.
MATERIALS AND METHODS
We performed a secondary analysis of data from the Oral Conditions and Pregnancy study 
(OCAP). The OCAP study was a prospective cohort study of maternal periodontal disease 
and obstetric outcomes performed at the Center for Oral and Systemic Disease, School of 
Dentistry, University of North Carolina in collaboration with Duke University Medical 
Center, Durham, North Carolina, from December 1997 through July 2001. The study design, 
procedures for subject enrollment, inclusion and exclusion criteria, clinical measurements, 
data collection methods, medical record abstraction, and biologic sampling methods were 
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described previously.22,23 The Duke University Medical Center and the University of North 
Carolina Institutional Review Boards granted approval to conduct the study, and written 
informed consent was obtained from all study participants. Over a 42-month period, eligible 
healthy women with a singleton pregnancy were enrolled at <26 weeks of gestation. 
Gestational age was calculated by the date of the last menstrual period and was confirmed 
by a first or second-trimester ultrasound examination. Demographic information, health 
behavior, and medical history data were obtained through subject interviews and 
questionnaires at the first visit and were reviewed by a physician at the first prenatal visit. 
Race was determined by self report. All women underwent periodontal examinations and 
maternal serum specimen collection at enrollment. Periodontal disease status was defined as 
healthy, mild, or moderate/severe, based on clinical criteria.24
CRP determination was performed with a commercially available highly sensitive enzyme-
linked immunosorbent assay (ELISA).§ The range of this assay is 0.5 to 50μg/ml with inter- 
and intra-assay variabilities of 3% and 15%, respectively.25 For this analysis, serum quartile 
levels of CRP ≥75%, which correspond to a level >15.7 μg/ml, were defined as elevated.26 
Subsequent to this analysis, these numbers were validated by Belo et al.26
Statistical analysis was performed with a statistical program.|| CRP levels were examined as 
continuous and ordinal values. Because our interquartile range (IQR) for serum CRP values 
included the traditional clinical cut-off of 10 μg/ml, we defined elevated CRP values as 
>75th percentile (>15.7 μg/ml) for our cohort of pregnant women. Bivariate analysis was 
performed to determine associations between maternal demographic characteristics and CRP 
using the χ2 test. These variables, which were statistically significant, along with smoking 
history, were included in a multivariable logistic regression model. Crude and adjusted odds 
ratios (ORs) and 95% confidence intervals (CIs) for elevated CRP were determined and 
stratified by periodontal disease and race. African American and white races were selected 
because they accounted for >95% of our cohort.
RESULTS
A total of 775 women had complete data and serum specimens available for this analysis. 
Demographic, medical, and obstetric data of the women who made up the cohort for this 
analysis are shown in Table 1. Although the cohort was distributed equally between African 
American and white women, African American women were significantly more likely to 
weigh more, to smoke, and to have experienced a prior preterm delivery and were less likely 
to be married or privately insured (Table 2).
The median gestational age at the time of enrollment was 14 weeks (range, 4 to 26 weeks). 
Median CRP value at the time of enrollment for all women was 4.8 μg/l (IQR: 0.63 to 15.7 
μg/l). African American women had significantly higher median CRP values at enrollment 
than white women (7.68 μg/ml versus 2.59 μg/ml; P <0.001). Moderate/severe periodontal 
disease was observed in 114 of 775 (15%) women in the study cohort. There was a 
§VIRGO C-Reactive Protein Kit, Hemagen Diagnostics, Waltham, MA.
||SAS version 9.1.3, SAS Institute, Cary, NC.
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significantly higher prevalence of moderate/severe periodontal disease in African American 
women than in white women (27% versus 5%; P <0.001).
African American race, maternal age, weight at enrollment, unmarried status, eligibility for 
a special supplemental nutritional program for women, infants, and children (WIC)/food 
stamps, lack of private insurance, previous preterm delivery, and moderate/severe 
periodontal disease were all significantly associated with elevated serum CRP levels (P 
≤0.03 for all parameters). Using multivariable logistic regression, moderate/severe 
periodontal disease (OR: 2.3; 95% CI: 1.3 to 4.4) and African American race (OR: 1.8; 95% 
CI: 1.1 to 2.9) were the strongest predictors of elevated CRP levels. Although smoking 
status was not associated with elevated CRP levels, it was included in the regression analysis 
because of its known association with periodontal disease.
The presence of moderate/severe periodontal disease was associated with a higher median 
CRP level compared to periodontal healthy or mild disease (10.5 μg/ml versus 3.0 μg/ml 
versus 4.9 μg/ml; P <0.0001). Significantly more women with moderate/severe periodontal 
disease had serum CRP levels >75th percentile than women with periodontal healthy or mild 
disease (42.5% versus 14.9% versus 25.6%; P <0.001). However, when stratified by race, 
moderate/severe periodontal disease remained associated with an elevated CRP among 
African Americans (adjusted OR: 4.0; 95% CI: 1.2 to 8.5) but not among white women 
(adjusted OR: 0.9; 95 CI: 0.2 to 3.6) after adjusting for age, smoking, prior preterm delivery, 
marital status, insurance status, and weight (Table 3).
DISCUSSION
In this study, we found that maternal periodontal disease was associated with maternal 
inflammation, as measured by CRP, among African American women but not white women. 
The reasons for this finding are unclear but may be explained by racial differences in oral 
microbiology, maternal genetic predisposition to proinflammatory responses to microbial 
challenges, or maternal behavioral differences that predispose to oral infection and 
subsequent inflammation. Alternatively, biologic differences such as genetic polymorphisms 
or hyperinflammatory genotypes may influence one’s susceptibility to oral pathogens or 
inflammatory responses.27 Social, cultural, and environmental factors may also play a role 
in oral health. African Americans and persons of low socioeconomic status have worse oral 
health measures than non-Hispanic white persons and those of high socioeconomic status. 28 
Compared to their African American counterparts with high socioeconomic status, African 
Americans with low socioeconomic status have more negative attitudes toward dental care, 
worse dental health, and are less likely to receive preventive dental care.28 As measured by 
marital status, insurance status, and enrollment in WIC/food stamps, the African American 
women in our cohort seemed to have a markedly lower socioeconomic status compared to 
the white women. Our data suggest that maternal serum CRP may serve as an additional 
marker for social disadvantage.
Our results are consistent with previous studies14,20,29 reporting that elevated levels of CRP 
during pregnancy are related to periodontal disease. Pitiphat et al.20 found 65% higher 
elevated median CRP levels among pregnant women with periodontitis compared to 
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periodontally healthy women (2.23 μg/ml versus 1.46 μg/ml). However, this study differed 
from ours with respect to the racial characteristics. More than 80% of the population studied 
was white, whereas only 5% of the population was African American. Herrera et al.29 also 
reported increasing median levels of CRP in women with periodontitis. In this case-control 
study, women with mild periodontitis had median CRP levels of 4.98 μg/ml, whereas 
women with moderate/severe periodontitis had median CRP levels of 8.16 μg/ml. This 
population of women is similar to our cohort of women with respect to very low 
socioeconomic status; however, <30% of the women were African American.
The recent development of highly sensitive CRP assays by nephelometry, which have 
decreased the discriminatory range for serum CRP values from 10 to <1 μg/ml, has allowed 
investigators to further explore the role of subclinical and low-grade inflammation in 
predicting and diagnosing pathology characterized by inflammation. The ELISA method 
used in this study had detection limits that approximate those levels (0.5 μg/ml). CRP is one 
of the most studied and validated measures of vascular inflammation.12 The usefulness of 
measuring serum CRP as a biomarker of cardiovascular risk has been well described.21,30 
Non-pregnant individuals with serum CRP levels >3 μg/ml are considered to be at high risk 
for future cardiovascular disease and events.31
Limited information is available on normal values of CRP in pregnancy. Early studies,32–34 
using older assays with less sensitivity and narrower discriminatory ranges over broad 
ranges of gestational ages, reported varying results regarding CRP levels in healthy pregnant 
women. This has limited the usefulness of CRP to screen or predict disease among pregnant 
women. Serum CRP levels are higher among pregnant women compared to non-pregnant 
women, confirming that pregnancy is associated with a low-grade maternal inflammatory 
response.26 Median CRP levels may fluctuate during pregnancy but are ~3 μg/ml throughout 
all trimesters of pregnancy. In a recent longitudinal study using the highly sensitive 
immunoassay for CRP, Belo et al.19 reported longitudinal data on CRP fluctuation on a 
small number of women during normal pregnancy. Compared to non-pregnant women, CRP 
levels were significantly higher in pregnant women. CRP levels remained fairly constant 
throughout gestation, with a median CRP level ~3 μg/ml; no values were >15 μg/ml.
The limitations of our study warrant discussion. This is a secondary analysis of data 
collected for the OCAP study in which CRP levels were measured in 76% of the women 
enrolled. This raises the concern for potential bias. However, maternal demographic 
characteristics and oral health status were similar among women with and without serum 
available for CRP testing (data not shown). In addition, although our cohort was evenly 
divided between African American and white women, significant differences existed in the 
sociodemographic characteristics of these two groups. If the racial groups had been better 
matched for socioeconomic characteristics, we may not have observed these racial 
differences in CRP. However, in our multivariable logistic model, elevations in serum CRP 
among women with periodontal disease persisted among African Americans, even after 
adjusting for possible confounding.
CRP is a non-specific marker of inflammation and is known to be elevated in persons with 
periodontal disease. 17,18 It is possible that our subject population had elevated CRP levels 
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for reasons that we were unable to account for or evaluate. We did not assess the presence or 
absence of dental caries and recognize that our cohort of women could have periapical 
inflammation in teeth with advanced caries that would have contributed to oral 
inflammation. It is also plausible that maternal periodontal disease is acting as a surrogate 
for some other maternal factor. The overall amount of periodontal disease in this pregnant 
population was not as severe or extensive as reported in other studies17,18 that examined the 
relationship between periodontal disease and CRP levels in older subjects with more 
periodontal disease.
CONCLUSIONS
As measured by CRP, African American women with moderate/severe periodontal disease 
evoke a high systemic inflammatory response early in pregnancy. Uncovering racial 
differences in maternal serum CRP levels and periodontal disease does not explain why 
these disparities exist, and the impact of these differences on adverse pregnancy outcomes is 
unknown. In addition, the role of maternal inflammation in response to periodontal infection 
in mediating adverse pregnancy outcomes remains to be explored, although Ruma et al.35 
demonstrated that the relationship between maternal periodontal disease and preeclampsia 
may be partially explained by maternal inflammation. Further research is needed to 
determine whether the treatment of periodontal disease decreases the burden of maternal 
systemic inflammation and impacts pregnancy outcomes. Because the implementation of 
dental services to underserved pregnant women with limited access to care is a daunting 
task, it may be possible to tailor preventive dental care to those women in greatest need 
and/or who are most likely to benefit. Understanding that African American women are at 
greater risk for moderate/severe periodontal disease compared to white women, which is 
associated with a significant inflammatory burden and potential adverse pregnancy 
outcomes, justifies further research in this at-risk population.
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Table 1
Demographic, Medical, and Obstetric Data for the Cohort
Subject Characteristics Entire Cohort (N = 775)
Maternal age (years; mean ± SD) 28 ± 6.5
Maternal weight at enrollment (pounds; mean ± SD) 162 ± 44.7
Maternal race (n [%])
 White 374 (48)
 African American 360 (46)
 Other (Asian, Hispanic, Native American) 41 (6)
Periodontal disease status (n [%])
 Healthy 211 (27)
 Mild 450 (58)
 Moderate/severe 114 (15)
CRP (μg/ml; mean ± SD) 12.6 ± 17.1
CRP (μg/ml; median [IQR]) 4.8 (0.63 to 15.7)
CRP >75th percentile (n [%]) 194 (25)
Married (n [%]) 394 (51)
Privately insured (n [%]) 358 (46)
Eligible for WIC/food stamps (n [%]) 171 (22)
Primigravida (n [%]) 308 (40)
Multiparous with previous preterm delivery (n [%]) 133 (28)
Sexually transmitted infection (n [%]) 97 (13)
Smoking during current pregnancy (n [%]) 132 (17)
Alcohol use during current pregnancy (n [%]) 122 (16)













Horton et al. Page 10
Table 2
Demographic, Medical, and Obstetric Data by Maternal Race
Subject Characteristics African American (n = 360) White (n = 374) P Value*
Maternal age (years; mean ± SD) 25.6 ± 5.9 30.3 ± 6.3 NS
Maternal weight at enrollment (pounds; mean ± SD) 167.3 ± 43 150.9 ± 38 0.009
CRP (μg/ml; mean ± SD) 17.3 ± 19.3 8.0 ± 13 <0.001
CRP (μg/ml; median [IQR]) 7.68 (1.88 to 31.7) 2.59 (0.16 to 9.95) <0.001
CRP >75th percentile (n [%]) 126 (35) 57 (15) <0.001
Periodontal disease status (n [%])
 Healthy 40 (11) 162 (43) NS
 Mild 235 (62) 191 (51) NS
 Moderate/severe 85 (27) 21 (5) <0.001
Married (n [%]) 81 (23) 278 (74) <0.001
Privately insured (n [%]) 70 (19) 264 (71) <0.001
Eligible for WIC/food stamps (n [%]) 129 (36) 38 (10) <0.001
Primigravida (n [%]) 117 (33) 175 (47) <0.001
Multiparous with previous preterm delivery (n [%]) 79 (22) 47 (13) <0.001
Sexually transmitted infection (n [%]) 69 (19) 27 (7) <0.001
Smoking during current pregnancy (n [%]) 74 (21) 57 (15) NS
Alcohol use during current pregnancy (n [%]) 48 (13) 73 (20) 0.02
NS = not statistically significant.
*
χ2 test.
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Table 3
Periodontal Disease Status, Maternal Race, and CRP ≥75th Percentile
Periodontal Disease/Race*
White African American
Adjusted OR (95% CI)†
Healthy 1.0 (reference) 0.7 (0.2 to 2.2)
Mild 1.1 (0.5 to 1.9) 2.9 (1.1 to 3.8)
Moderate/severe 0.9 (0.2 to 3.6) 4.0 (1.2 to 8.5)
*
Based on 734 women of African American and white race.
†
Adjusted for age, smoking, prior preterm delivery, marital status, insurance status, and weight.
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